Life Science Equipment Market by Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Lab Automation, Microarray, Electrophoresis, Incubator, Centrifuge) End User - Global Forecast to 2030

Life Science Equipment Market By Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Lab Automation, Microarray, Electrophoresis, Incubator, Centrifuge) End User– Global Forecast to 2030

The life science equipment market is expected to reach $92.21 billion by 2030, at a CAGR of 6.2% from 2023 to 2030.

After extensive primary and secondary research, the report provides an in-depth analysis of the life science equipment market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the life science equipment market. The growth of the life science equipment market is driven by the increasing pharmaceutical and biotech R&D expenditures, government initiatives supporting life sciences R&D, the increasing prevalence of chronic and infectious diseases, and growth in initiatives to control environmental pollution. However, the high costs of advanced equipment and funding and infrastructure limitations in developing countries restrain the growth of this market.

Furthermore, the growth in genomics and proteomics, the increasing awareness and growing adoption of personalized medicines, increasing automation and digitalization in the life sciences industry, and the increasing focus on food safety and quality are generating growth opportunities for the players operating in this market. However, the lack of skilled professionals required for operating advanced laboratory equipment and data security concerns are major challenges for market stakeholders.

Among the technologies included in the report, in 2023, the sequencing segment is projected to register the highest CAGR during the forecast period. The capability of sequencing technology to generate high-yield error-free throughput, the growing integration of this technology in clinical and research settings, and increasing partnerships and collaborations among sequencing instrument manufacturers to expand and improve product offerings are some of the factors contributing to the growth of the segment.

Among the end users included in the report, in 2023, the pharmaceutical and biotechnology industry segment is estimated to account for the largest share of the life science equipment market. The large market segment share is majorly attributed to the increased attention towards personalized medicine, growth in the number of research studies covering biologics and biosimilars, and growing collaborations among pharmaceutical & biotechnology companies and CROs.

An in-depth analysis of the geographical scenario of the life science equipment market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the life science equipment market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The high prevalence of chronic and infectious diseases leading to a large number of approvals of biosimilars and generics, high adoption of advanced technologies, a well-established healthcare system, and increased funding activities for life science research are some of the factors supporting the largest share of this market.

The key players operating in the life science equipment market are Agilent Technologies, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann LA-Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers AG (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and Qiagen N.V. (Netherlands).

Scope of the Report:

Life Science Equipment Market Assessment—by Technology

Spectroscopy
Molecular Spectroscopy
UV/Vis Spectroscopy
Nuclear Magnetic Resonance (NMR)
Near-Infrared (NIR) Spectroscopy
Infrared (IR) Spectroscopy
Raman Spectroscopy
Polarimeters and Refractometers
Fluorescence & Luminescence Spectroscopy
Other Molecular Spectroscopy Technologies

Note:Other molecular spectroscopy technologies segment includes Raman spectroscopy, ellipsometry, and color measurement.

Mass Spectrometry
Quadrupole LC/MS
Time of Flight LC/MS (Q-TOF & LC-TOF)
Gas Chromatography-Mass Spectrometry (GC/MS)
Fourier Transform Mass Spectrometry (FT/MS)
Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectroscopy (MALDI-TOF MS)
Portable and In-Field Mass Spectroscopy
Tandem Mass Spectroscopy (MS/MS)
Ion Trap Mass Spectroscopy (LC/MS)
Atomic Spectroscopy
Atomic Absorbance Spectroscopy (AAS)
X-Ray Fluorescence (XRF) Spectroscopy
X-Ray Diffraction (XRD) Spectroscopy
Other Atomic Spectroscopy Technologies

Note:Other atomic spectroscopy technologies segment includes inductively coupled plasma (ICP) spectroscopy, glow discharge spectroscopy, and arc/spark optical emission spectroscopy.

Spectroscopy Software
Microscopy
Electron Microscopy
Optical Microscopy
Scanning Probe Microscopy
Other Microscopy
Microscopy Software
Chromatography
High-Performance Liquid Chromatography (HPLC)
Gas Chromatography (GC)
Low Pressure Liquid Chromatography (LPLC)
Flash Chromatography
Thin Layer Chromatography (TLC)
Ion Chromatography
Supercritical Fluid Chromatography (SFC)
Chromatography Software
Lab Automation
Automated Workstations
Robotic Systems
Automated Storage and Retrieval Systems (ASRS)
Lab Automation Software
Immunoassay Analyzers
Chemiluminescence Immunoassay
Fluorescence Immunoassay
Radioimmunoassay (RIA)
Colorimetric Immunoassay
Other Immunoassay Analyzers
Immunoassay Software
PCR
RT-PCR
Conventional PCR
Digital PCR
PCR Software
Sequencing
Flow Cytometry
Cell-Based Flow Cytometers
Bead-Based Flow Cytometers
Flow Cytometry Software
Incubators
Microarray
DNA Microarrays
Protein Microarray
Tissue Array
Other Microarrays
Microarray Software

Note:Other microarrays segment includes glycan microarray, carbohydrate microarray, and chemical compounds microarray.

Centrifuges

Centrifuges, by Type

Devices
Multipurpose Centrifuges
Microcentrifuges
Mini-centrifuges
Ultracentrifuges
Other Centrifuges
Centrifuge Accessories

Centrifuges, by Model

Benchtop Centrifuges
Floor-standing Centrifuges

Centrifuges, by Application

Research Applications
Genomics
Microbiology
Cellomics
Proteomics
Clinical Applications
Diagnostics
Blood Processing and Screening
Other Applications
Electrophoresis
Gel Electrophoresis
Capillary Electrophoresis
Gel Documentation Systems and Software
Other Equipment

Note:Other equipment segment includes autoclaves, stirrers & shakers, mixers, baths, hot plates, ovens & furnaces, and balances.

Life Science Equipment Market Assessment - by End User

Pharmaceutical and Biotechnology Industry
Academic & Research Institutes
Hospitals and Diagnostic Laboratories
Analytical Testing Laboratories
Agriculture and Food Industry
Forensic Laboratories
Other End Users

Note:Other end users include blood banks and industries, such as cosmetics, chemicals, oil & gas, electronics & semiconductors, automotive, aerospace, ceramics, plastics, rubber, and paints & coatings.

Life Science Equipment Market Assessment - by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Switzerland
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
South Korea
Rest of APAC (RoAPAC)
Latin America
Brazil
Mexico
Rest of LATAM (RoLATAM)
Middle East & Africa
Saudi Arabia
UAE
Rest of Middle East & Africa (RoMEA)

Life Science Equipment Market - Global Opportunity Analysis and Industry Forecast (2023–2030) - Report Summary

Report Metrics	Details
Years Considered	2021 - 2030
Base Year	2022
Forecast Period	2023-2030
Page Count	686
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Technology and End User
Regions Covered	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Key Companies Mentioned	Agilent Technologies, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann LA-Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers AG (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and QIAGEN N.V. (Netherlands)

FAQs About the Report

What is the focus of the life science equipment study?

This study offers a detailed assessment of the life science equipment market, including the market sizes & forecasts for market segments such as technology and end user. The study also provides an in-depth analysis of various segments & subsegments of the life science equipment at the regional and country levels.

What is the revenue generated from the sale of life science equipment across the globe? At what rate is their demand expected to grow for the next 5–7 years?

The life science equipment market is projected to reach $92.21 billion by 2030, at a CAGR of 6.2% during the forecast period.

Based on technology, which segment is expected to account for the largest share of the market in 2023?

In 2023, the spectroscopy segment is expected to account for the largest share. The wide range of applications, high precision and sensitivity, advancements in technology, and large user base contribute to the large market share of this segment.

Based on end user, which segment is slated to grow fastest over the forecast period?

Based on end user, the hospitals and diagnostic laboratories segment is expected to grow with the highest CAGR due to growth in the number of hospitals and diagnostic laboratories and initiatives to increase diagnostic capabilities of the hospitals due to the emergence of sudden pandemic situations.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the life science equipment market?

The growth of this market is attributed to several factors, including increasing funding and investment in the pharma, biotech, and life science industries, government initiatives to strengthen R&D for biotech and life sciences, rising prevalence of chronic diseases, and growing clinical capabilities globally. Additionally, the growth in genomics and proteomics, increasing awareness, growing adoption of personalized medicine, and emerging economies are expected to provide significant opportunities for players operating in the market.

Who are the major players operating in the life science equipment market?

The key players profiled in the life science equipment study are Agilent Technologies, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Waters Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and QIAGEN N.V. (Germany).

Which regions/countries are expected to dominate the life science equipment market in 2023?

In 2023, North America is expected to dominate the life science equipment market. North America’s major market share is attributed to the presence of key market players, the well-established life science industry, and substantial spending on R&D activities by pharmaceutical and biotech companies.